• BX Home
  • Merck & Co.: News [Page 5]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MERCK & CO.

Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.

Merck & Co. is part of Business Exchange, suggested by Ginny Moore. This topic contains 969 news and 178 blog items. Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from like-minded professionals.

News

Please add new articles to this topic

Schadt Joins Mount Sinai Medical Schoolmore

simulating them on computers. He spent much of his career at Rosetta Inpharmatics, a genomics company acquired by Merck.

Mastercard, Apache: New Targets, Estimatesmore

Also see: Accenture, JetBlue: Analysts' New Ratings More on A Market Activity Agilent Technologies Inc.

Stocks to Watch: Merck, Lilly, TMX and Moremore

Extract not available.

A.M. Vitals: WellPoint Will Tie Payment to Qualitymore

Extract not available.

Pharma majors take JV route to Indiamore

joint venture with Zydus Cadila to sell drugs in India and in April, Sun Pharmaceutical Industries and US-based Merck...

News Corp to reveal political donationsmore

each January, the company said. The Associated Press earlier reported on the News Corp statement. Prudential Financial...

FDA approves Merck drugmore

Merck & Co. won U.S. approval Friday for the first hepatitis C drug in almost a decade after studies showed it...

Aruba Networks, GM, Juniper, Rosetta Stone: U.S. Equity Previewmore

percent or more over the next year, Barron���s reported, citing Brian Marshall, analyst at Gleacher & Co.

Need A Job? Try Church.more

Extract not available.

FDA approves Merck drugmore

Merck & Co. won U.S. approval Friday for the first hepatitis C drug in almost a decade after studies showed it...

FDA Approves Merck's VICTRELIS���� (boceprevir), First-in-Class Oral H...more

/PRNewswire/ -- Merck (NYSE: MRK) (known as MSD outside the United States and Canada) announced today that the U.S.

Benihana, Conmed Healthcare, Merck, Siga: U.S. Equity Previewmore

offers health-care services in jails and prisons hired Gleacher & Co. to explore a potential sale or acquisitions.

US FDA clears new Merck drug for hepatitis Cmore

Merck & Co won US approval on Friday to sell a new drug considered a major advance against the liver-destroying...

Merck���s Hepatitis C Drug Wins F.D.A. Approvalmore

promises to increase the cure rate while shortening the time required for treatment. The new drug, Victrelis from...

Merck hepatitis C drug approved by FDAmore

Extract not available.

F.D.A. Approves New Hepatitis C Drugmore

A. approval later this month for its own hepatitis C protease inhibitor, and a fierce marketing war with Merck is...

F.D.A. Approves New Drug for Hepatitis Cmore

A. approval later this month for its own hepatitis C protease inhibitor, and a fierce marketing war with Merck is...

SIGA Technologies: After-Hours Tradingmore

from the federal government to provide two million courses of its smallpox antiviral medication ST-246.

US HOT STOCKS: Merck Shares Active In Late Tradingmore

Extract not available.

UPDATE 3-U.S. FDA clears new Merck drug for hepatitis Cmore

* Victrelis seen as major advance against liver disease * Analysts forecast blockbuster sales * Merck shares gain 0.

UPDATE 2-U.S. FDA clears new Merck drug for hepatitis Cmore

* Victrelis seen as major advance against liver disease * Analysts forecast blockbuster sales * Merck shares gain 0.

FDA Clears Merck Hepatitis Drugmore

Extract not available.

Merck Hep C Drug Approvedmore

WHITEHOUSE STATION, NJ (TheStreet) --U.S. regulators on Friday approved a new hepatitis C drug from Merck(MRK).

UPDATE 1-U.S. FDA clears new Merck drug for hepatitis Cmore

Merck & Co (MRK.N) won U.S. approval on Friday to sell a new drug considered a major advance against the liver...

Early Treatment Could Avert Millions of AIDS Cases, Study Showsmore

City, California-based Gilead, New York-based Bristol- Myers, Abbott Laboratories of Abbott Park, Illinois, German...

Top Sources: Merck & Co.

  • Reuters
  • BusinessWeek
  • Philadelphia Inquirer
  • MarketWatch
  • Wall Street Journal Online
  • Financial Times
  • businesswire.com
  • Forbes.com
  • latimes.com
  • inpharm.com

Most Active Users in this Topic

see all contributors in Merck & Co.

Featured White Papers

Post a Job

Jobs in this Topic

Senior Scientist Merck & Co | Rahway, NJ
Posted: May 17
Security - Current Sovereign/Merck Employees apply here Job Barton | West Point, PA
Posted: May 14
Security - Current Sovereign/Merck Employees apply here Job Alliedbarton | West Point, PA
Posted: Apr 17
Sovereign/Merck Employees Only Job Barton | North Wales, PA
Posted: May 11

Report comment contains invalid characters. ()
cancel
Search Cancel